Ligand validation:6Y9D

EPE: 4-(2-HYDROXYETHYL)-1-PIPERAZINE ETHANESULFONIC ACID

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6Y9D_EPE_A_405	4%	16%	0.257	0.634	2.28	1.41	1	3	0	0	100%	1
6Y9D_EPE_J_405	4%	20%	0.236	0.599	2.12	1.26	1	2	3	0	100%	1
6Y9D_EPE_I_405	3%	28%	0.257	0.606	1.04	1.82	1	6	0	0	100%	1
6Y9D_EPE_L_405	3%	30%	0.343	0.677	0.96	1.81	1	9	0	0	100%	1
6Y9D_EPE_H_405	2%	30%	0.311	0.619	1.07	1.7	1	8	0	0	100%	1
6Y9D_EPE_D_405	2%	27%	0.305	0.594	0.96	1.94	1	8	0	0	100%	1
6Y9D_EPE_B_405	2%	30%	0.303	0.581	0.98	1.8	1	6	0	0	100%	1
6Y9D_EPE_K_405	2%	31%	0.289	0.531	0.97	1.74	1	7	0	0	100%	1
6Y9D_EPE_F_405	1%	30%	0.384	0.586	1.07	1.71	1	5	0	0	100%	1
6Y9D_EPE_C_405	1%	30%	0.412	0.588	1.13	1.66	1	5	0	0	100%	1
6Y9D_EPE_E_405	1%	29%	0.339	0.489	1.03	1.79	1	6	0	0	100%	1
6Y9D_EPE_G_405	1%	30%	0.329	0.477	1.06	1.72	1	4	0	0	100%	1
6ZGP_EPE_E_404	13%	24%	0.254	0.791	1.22	1.88	1	5	1	0	100%	1
1XX1_EPE_C_2003	100%	37%	0.024	0.996	0.73	1.72	1	4	1	0	100%	1
3EC7_EPE_E_401	100%	10%	0.031	0.993	1.1	3.18	1	11	1	0	100%	1
2BDU_EPE_B_402	100%	29%	0.033	0.993	0.87	1.95	1	5	0	0	100%	1
1CZB_EPE_A_300	100%	65%	0.04	0.991	0.69	0.67	-	-	0	0	100%	1
8VCQ_EPE_F_201	100%	60%	0.044	0.984	0.85	0.68	1	-	1	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.